Product Information
LEVOCETIRIZINE 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0534 per EA under NDC 33342020010. Its NADAC has been published 490 times since Feb 8, 2017.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342020010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205564On Market Since
1/11/2016
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 5 MG TABLET has been published 490 times since Feb 8, 2017, and over the history we have for it it has declined 60.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0534 per EA |
|---|---|
| All-time high | $0.2097 (May 16, 2018) |
| All-time low | $0.0534 (Jun 17, 2026) |
| 52-week high | $0.0617 |
| 52-week low | $0.0534 |
| Median price | $0.0772 |
| Average price | $0.0844 |
| Largest weekly change | +51.3% (Apr 18, 2018) |
| Weeks tracked | 490 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the LEVOCETIRIZINE DIHYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0534 per EA (NDC 33342020010), effective Jun 24, 2026.
How has the price of LEVOCETIRIZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 5 MG TABLET has declined 60.7%. It has been tracked across 490 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 5 MG TABLET?
Since Feb 8, 2017, the NADAC for LEVOCETIRIZINE 5 MG TABLET has ranged from a low of $0.0534 (Jun 17, 2026) to a high of $0.2097 (May 16, 2018), with a median of $0.0772 per EA.
Are there cheaper alternatives to LEVOCETIRIZINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LEVOCETIRIZINE 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures LEVOCETIRIZINE 5 MG TABLET?
LEVOCETIRIZINE 5 MG TABLET (NDC 33342020010) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification